TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2025 Earnings Conference Call May 5, 2025 8:30 AM ET
Company Participants
Jenna Bosco – Chief Communications Officer
Michael Weiss – Chairman and Chief Executive Officer
Adam Waldman – Chief Commercialization Officer
Sean Power – Chief Financial Officer
Conference Call Participants
Tara Bancroft – TD Cowen
Michael DiFiore – Evercore ISI
Roger Song – Jefferies
Mayank Mamtani – B. Riley Securities
Prakhar Agrawal – Cantor Fitzgerald
Operator
Greetings, and welcome to TG Therapeutics First Quarter Conference Call and Webcast. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Jenna Bosco, Chief Communications Officer. Thank you. You may begin.
Jenna Bosco
Thank you. Welcome, everyone, and thanks for joining us this morning. I’m Jenna Bosco, and with me today to discuss the first quarter 2025 financial results are Michael Weiss, our Chairman and Chief Executive Officer; Adam Waldman, our Chief Commercialization Officer; and Sean Power, our Chief Financial Officer. Following our safe harbor statement, Mike will provide an overview of our recent corporate developments, Adam will share an update on our commercialization efforts, and Sean will give a summary of our financial results before turning the call over to the operator to begin the Q&A session.
Before we begin, I’d like to remind everyone that we will be making forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements about our anticipated future operating and financial performance, including sales performance, projected milestones, revenue guidance, development plans and expectations for our marketed products. TG cautions that these forward-looking statements are subject to risks that may cause our actual results to differ materially from those indicated. Factors that may
#Therapeutics #TGTX #Earnings #Call #Transcript